{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:36:32Z","timestamp":1777628192433,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773948"],"award-info":[{"award-number":["81773948"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["J1103507"],"award-info":[{"award-number":["J1103507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["J1210025"],"award-info":[{"award-number":["J1210025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019155","name":"Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008964","name":"Nanjing Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.molpha.2026.100105","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:28:30Z","timestamp":1770078510000},"page":"100105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cepharanthine, a valuable sanative alternative for hepatocellular carcinoma through regulating Hippo-Yes-associated protein signal transduction"],"prefix":"10.1016","volume":"108","author":[{"given":"Kejun","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5747-2484","authenticated-orcid":false,"given":"Yukai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangwang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanhuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanglin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.molpha.2026.100105_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.molpha.2026.100105_bib2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","article-title":"Hepatocellular carcinoma incidence, mortality, and survival trends in the United States From 1975 to 2005","volume":"27","author":"Altekruse","year":"2009","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.molpha.2026.100105_bib3","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","article-title":"YAP1 increases organ size and expands undifferentiated progenitor cells","volume":"17","author":"Camargo","year":"2007","journal-title":"Curr Biol"},{"issue":"11","key":"10.1016\/j.molpha.2026.100105_bib4","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112126","article-title":"Two Hippo signaling modules orchestrate liver size and tumorigenesis","volume":"42","author":"Qi","year":"2023","journal-title":"EMBO J"},{"key":"10.1016\/j.molpha.2026.100105_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215640","article-title":"ETV4 potentiates nuclear YAP retention and activities to enhance the progression of hepatocellular carcinoma","volume":"537","author":"Xu","year":"2022","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.molpha.2026.100105_bib6","first-page":"1080","article-title":"Expression of Yes-associated protein in liver cancer and its correlation with clinicopathological features and prognosis of liver cancer patients","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.molpha.2026.100105_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-pathol-030420-105050","article-title":"The hippo pathway in liver homeostasis and pathophysiology","volume":"16","author":"Driskill","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.molpha.2026.100105_bib8","first-page":"1","article-title":"Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma","volume":"2014","author":"Han","year":"2014","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.molpha.2026.100105_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jep.2012.10.052","article-title":"New antiplasmodial alkaloids from Stephania rotunda","volume":"145","author":"Baghdikian","year":"2013","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100105_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13002-015-0019-1","article-title":"Ethnobotanical study on medicinal plants used by Maonan people in China","volume":"11","author":"Hong","year":"2015","journal-title":"J Ethnobiol Ethnomed"},{"issue":"1","key":"10.1016\/j.molpha.2026.100105_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.aat.2015.11.004","article-title":"Cepharanthine alleviates liver injury in a rodent model of limb ischemia\u2013reperfusion","volume":"54","author":"Chang","year":"2016","journal-title":"Acta Anaesthesiol Taiwan"},{"issue":"1","key":"10.1016\/j.molpha.2026.100105_bib12","first-page":"93","article-title":"Biscoclaurine alkaloid cepharanthine protects DNA in TK6 lymphoblastoid cells from constitutive oxidative damage","volume":"60","author":"Halicka","year":"2008","journal-title":"Pharmacol Rep"},{"issue":"14","key":"10.1016\/j.molpha.2026.100105_bib13","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/aid.1998.14.1239","article-title":"Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells","volume":"14","author":"Okamoto","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"10.1016\/j.molpha.2026.100105_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/biom9110696","article-title":"Natural bis-benzylisoquinoline alkaloids-tetrandrine, fangchinoline, and cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells","volume":"9","author":"Kim","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.molpha.2026.100105_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110151","article-title":"Cepharanthine attenuates cerebral ischemia\/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12\/15-LOX signaling","volume":"127","author":"Zhao","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.molpha.2026.100105_bib16","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1159\/000471234","article-title":"Cepharanthine induces autophagy, apoptosis and cell cycle arrest in breast cancer cells","volume":"41","author":"Gao","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"suppl","key":"10.1016\/j.molpha.2026.100105_bib17","first-page":"149","article-title":"Cepharanthine suppresses metastatic potential of human cholangiocarcinoma cell lines","volume":"13","author":"Uthaisar","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.molpha.2026.100105_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2017.09.009","article-title":"Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth","volume":"409","author":"Lyu","year":"2017","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.molpha.2026.100105_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","article-title":"Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers","volume":"42","author":"Wang","year":"2023","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"10.1016\/j.molpha.2026.100105_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41575-019-0165-3","article-title":"The role of telomeres and telomerase in cirrhosis and liver cancer","volume":"16","author":"Nault","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.molpha.2026.100105_bib21","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","article-title":"Hippo pathway activity influences liver cell fate","volume":"157","author":"Yimlamai","year":"2014","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.molpha.2026.100105_bib22","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2015.02.027","article-title":"YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression","volume":"10","author":"Fitamant","year":"2015","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.molpha.2026.100105_bib23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1096\/fj.14-262980","article-title":"Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides","volume":"29","author":"Zhou","year":"2015","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.molpha.2026.100105_bib24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.trecan.2020.12.001","article-title":"Targeting CTGF in cancer: an emerging therapeutic opportunity","volume":"7","author":"Shen","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.molpha.2026.100105_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152956","article-title":"Cepharanthine: an update of its mode of action, pharmacological properties and medical applications","volume":"62","author":"Bailly","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.molpha.2026.100105_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/JHC.S168953","article-title":"Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date","volume":"6","author":"Personeni","year":"2019","journal-title":"J Hepatocell Carcinoma"},{"issue":"10","key":"10.1016\/j.molpha.2026.100105_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0159-1","article-title":"Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors","volume":"50","author":"M\u00e9ndez-Blanco","year":"2018","journal-title":"Exp Mol Med"},{"issue":"3","key":"10.1016\/j.molpha.2026.100105_bib28","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of \u03b2-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice","volume":"147","author":"Tao","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.molpha.2026.100105_bib29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s13402-021-00595-z","article-title":"YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin","volume":"44","author":"Sun","year":"2021","journal-title":"Cell Oncol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100105_bib30","article-title":"Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"issue":"15","key":"10.1016\/j.molpha.2026.100105_bib31","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.7150\/ijbs.64675","article-title":"Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo","volume":"17","author":"Feng","year":"2021","journal-title":"Int J Biol Sci"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:35:24Z","timestamp":1777426524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X26000052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0026895X26000052"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100105","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cepharanthine, a valuable sanative alternative for hepatocellular carcinoma through regulating Hippo-Yes-associated protein signal transduction","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100105"}}